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Objective: To explore the expression of Netrin-1 protein in human renal clear cell
carcinoma (RCCC) and the relationships between Netrin-1, pathology and prognosis.
Methods: 72 cases of RCCC admitted in our hospital from 2008 June to 2009 June and
their adjacent tissues were selected for study. They included 30 cases in stage Ⅰ–Ⅱ, 42
cases in stage Ⅲ–Ⅳ; 9 cases in grade Ⅰ, 9 cases in grade Ⅱ, 40 cases in grade Ⅲ and 14
cases in grade Ⅳ. All cases were followed up for more than 5 years. Survival analysis
lines were made by Kaplan–Meier method and the difference between groups was tested
by the Log-rank test. The expression of Netrin-1 protein was detected by immunohis-
tochemistry staining and its clinical signiﬁcance was analyzed.
Results: Renal clear cell carcinoma: 51 cases in high expression of Netrin-1 and 21 cases
in low expression, normal tissues: 12 cases in high expression of Netrin-1 and 60 cases in
low expression, the difference between the two groups is signiﬁcant (c2 = 42.921,
P ＜ 0.01). The difference of the expression of Netrin-1in Fuhrman grade and AJCC
clinical stage is signiﬁcant (c2 = 8.000, c2 = 6.203; P＜0.05). The 5-year survival rate in
low protein expression group and in high protein expression group was 79％ (17/21) and
62％ (32/51). The survival curve had different trend, with no signiﬁcant difference be-
tween groups ((c2 = 1.360, P = 0.245).
Conclusions: Netrin-1 protein plays an important role in the development of RCCC. It
might be a new speciﬁc tumor marker of RCCC, and might become a new target in
treatment of RCCC.1. Introduction
Renal clear cell carcinoma (RCCC), accounting for about
80% of renal malignant tumors, is one of the most common
malignant tumor of the urinary system. The incidence of RCCC
in China shows an increasing trend year by year [1]. It has
changeable biological behavior, complex etiology and poor
prognosis. It has become a current research hotspot to study
the key factors of the occurrence and development of RCCC
and how to improve the survival rate of the patients [2]. In
recent years, many researchers concerned with the study on
the correlation between the occurrence and development of
tumor and Netrin-1. It has been found that Netrin-1 not only
plays an important role in neural migration, neural guide andneural plasticity [3], but also can guide the growth of the
glandular system and the vascular system, adjust the
migration of white cell, exert a synergistic inhibition effect
with the colorectal cancer homologous protein or the missing
gene protein, or induce the apoptosis of tumor cell [4]. So
Netrin-1 probably is a type of cancer gene and involved in
the occurrence and development of tumor. In the study the
Netrin-1 protein in RCCC tissues was detected by immuno-
histochemistry staining to explore its relationship with the
occurrence and development of RCCC and its clinical
signiﬁcance.
2. Materials and methods
2.1. Clinical data
A total of 72 RCCC cases admitted in our hospital from 2008
June to 2009 June were selected for study, including 39 male
cases and 33 female cases, ranging in age from 27 to 84 years
old with a mean age of (56 ± 12) years old. Selection criteria ofccess article under the CC BY-NC-ND
Table 1
Expression of Netrin-1 in 72 cases of RCCC.
Item Number
of cases
Expression of Netrin-1 c2 value P value
Low
expression
High
expression
Gender
Male 39 12 27 0.106 0.75
Female 33 9 24
Age
＜60 39 13 26 1.309 0.253
60 33 7 26
Fuhrman grade
Ⅰ–Ⅱ 18 9 9 8.000 ＜0.01
Ⅲ–Ⅳ 54 9 45
AJCC clinical stage
Ⅰ–Ⅱ 30 13 17 6.203 0.01
Ⅲ–Ⅳ 42 7 35
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②The patients were diagnosed by routine pathological exami-
nations; ③The patients were without biological treatment and
radiotherapy and chemotherapy before the operation. The cancer
tissues conﬁrmed by pathological examinations removed in
operation and their adjacent noncancerous tissues 2 cm beside
the carcinoma were collected. The selected samples were
embedded in parafﬁn and made into 4 mm sections. They
included 30 cases in stage Ⅰ–Ⅱ, 42 cases in stageⅢ–Ⅳ; 9 cases in
grade Ⅰ, 9 cases in grade Ⅱ, 40 cases in grade Ⅲ and 14 cases in
grade Ⅳ.
2.2. Experimental reagents and methods
Immunohistochemical SP method was used. The primary
antibody of Netrin-1, goat anti human polyclonal antibody,
was bought from the British company Abcam. And the sec-
ondary antibody, rabbit anti goat SP kit, was bought from
Fuzhou Maixin Biological Technology Development Com-
pany. The working concentration of the primary antibody was
1:100. The experimental procedure was carried out strictly in
accordance with the instruction of the kit. Antigen repairing
with citrate and DAB color was performed in parafﬁn sec-
tions after deparafﬁnating. The sections were stained with
hematoxylin, dehydrated and sealed transparently. With the
phosphate buffer solution as a negative control instead of the
primary antibody and the known positive sections as a pos-
itive control, the sections were observed under the micro-
scope [5].
2.3. Evaluation index
In the case of double-blind pathological and clinical data, the
visual ﬁelds were selected by two pathologists and the ratio of
positive staining cells and the total number of tumor cells was
recorded. The results were determined separately and conﬁrmed
ﬁnally through discussion. Five high power ﬁelds (×400) were
selected randomly in the samples of each patients, and the
staining intensity and percentage of positive cells were selected
as the reference index according to the related references [6].
Staining intensity was as follows: 0 score for no colouring, 1
score for pale yellow, 2 scores for brown yellow and 3 scores
for brown; percentage of positive cells was as follows:
0 score for 10%, 1 score for 11%–25%, 2 scores for 26%–Figure 1. Expression of Netrin-1 in normal tissues adjacent to carcinoma and
A shows the low expression of Netrin-1 in normal tissues adjacent to carcinom50% and 3 scores for ＞50%. The product of two scores was
used as the basis of judgment. A sore of not less than 3
means high expression and a score of less than 3 means low
expression.
2.4. Statistical analysis
All the data were processed using SPSS17.0 statistical soft-
ware. According to the relationship between the clinical path-
ological parameters of RCCC and the expression level of
Netrin-1 protein, a Fisher exact test or chi square test was
used to analyze the difference between clinical data. The sur-
vival times were compared using Log-Rank (Mantel–Cox) test,
and the survival rates were calculated using Kaplan–Meier
method. A P value＜0.05 was considered as statistically
signiﬁcantly different.
3. Results
3.1. Expression results of Netrin-1 in normal tissues
adjacent to carcinoma and RCCC tissues
The Netrin-1 showed low expression in normal tissues
adjacent to carcinoma and showed high expression in RCCC
tissues with expression in the nucleus and cytoplasm (Figure 1).
There were 51 cases in high expression of Netrin-1 and 21 casesRCCC tissues.
a, and B shows the high expression of Netrin-1 in RCCC.
Figure 2. Expression of Netrin-1 protein in different pathological grade of RCCC tissues.
A: Fuhrman Ⅱ stage; B: Fuhrman Ⅲ stage; C: Fuhrman Ⅳ stage.
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60 cases in low expression, the difference between the two
groups was signiﬁcant (c2 = 42.921, P ＜ 0.01).
3.2. Relationship between the clinical pathological
features of RCCC and the positive expression of Netrin-1
The difference of the positive expression of Netrin-1 in 72
cases of RCCC in age and gender was not statistically signiﬁcant
(P＞ 0.05), while the difference of the expression of Netrin-1 in
pathological grade and clinical stage was statistically signiﬁcant
(P < 0.05) (Table 1). In Fuhrman grade Ⅳ, Netrin-1 was also
expressed within the nucleus in addition to the cytoplasm
(Figure 2).
3.3. Analysis of the correlation between the
postoperative survival rates of patients with RCCC and
the expression of Netrin-1 protein
The 72 cases of RCCC had been followed up for more than
5 years by December, 2014. The 5-year survival rate after
operation in low protein expression group and in high protein
expression group was 79％ (17/21) and 62％ (32/51). Survival
curves were made by Kaplan–Meier method and then the dif-
ference between groups was analyzed by the Log-rank
(Mantel–Cox) test. There was no signiﬁcant difference inFigure 3. Survival curves after operation of patients with RCCC in low
Netrin-1 expression group (21 cases) and in high Netrin-1 expression group
(51 cases).survival rate between two group (c2 = 1.360, P = 0.245)
(Figure 3).
4. Discussion
4.1. Research status of Netrin-1 protein
Netrin-1 protein was found through the genetic analysis of
UNC-6 deletion mutant of nematode. With a molecular weight
of about 70–80 kD, Netrin-1 protein shows a high expression in
the ventral area of ventricle and the bottom plate of spinal cord
in development, and combines the location and growth of neu-
rons by stimulating the growth of spinal cord [7]. As a homolog
of UNC-6 in spinal animal, Netrin-1 protein is similar to laminin
in structure. It is expressed in many parts of the body, such as the
neuroglial cell in the ventral spinal cord, the internal capsule, the
ventral area of lateral ventricle, and the cerebellar cortex in the
nervous system; and the pancreas, the acinus of mammary gland,
the myocardial cell, the dorsal part of artery and the ovary in the
non nervous system [8]. Netrin-1 protein combines with trans-
membrane receptor like immunoglobulin to transfer signals
through dependent receptor [9]. As one of the axon guidance
factors in Netrin family, Netrin-1 protein is highly expressed
in the nervous system, and involved in the axonal directional
migration and growth as well as the neuronal development and
differentiation. It plays a role of repulsion or attraction on axon
according to different binding receptors in the development of
central nervous system. Netrin-1 protein can direct cell migra-
tion and regulate axonal growth in the embryonic neural growth
and development, and can also play roles of inducing cell
migration, resisting apoptosis and regulating the formation of
axonal direction when the adult central nervous system is
damaged [10]. The nervous system is structurally similar to the
vascular system, and the neuron and vessel are similar in
growth pattern, so Netrin signal also play a role in the
vascular system. It has been shown that Netrin-1 protein can
promote the migration, proliferation and adhesion of endothelial
cell, and the effect of VEGF. It has also been found to promote
the formation of the artery as well as the micrangium [11]. The
relationship between Netrin-1 and tumor formation becomes
more and more important in our study. It has been found that the
expression of Netrin-1 increases signiﬁcantly in 47% patients
with non small cell carcinoma [12], and it is also high in 7%
patients with colon cancer [13]. The induced high expression of
Netrin-1 in gastrointestinal tissues can reduce cell apoptosis
and induce the occurrence of cancer. Netrin-1 protein inﬂuences
the occurrence and development of gastric cancer by regulating
the tumor cells, and helps evaluate the survival time and the
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A variety of tumor tissues show high expression of Netrin-1
protein, such as metastatic breast cancer [14], neuroblastoma,
non small cell lung cancer and pancreatic cancer [15]. And the
current clinical treatment effect of these tumors is not ideal,
needing more effective treatments. Ii is suggested that we need
to have a deeper understanding of such molecules, and study
its function in the occurrence and development of tumor.
4.2. Analysis of Netrin-1 protein expression
The expression of Netrin-1 in normal tissues adjacent to
carcinoma and RCCC tissues was detected by immunohisto-
chemistry staining in this study. There were 51 cases in high
expression of Netrin-1 and 21 cases in low expression in RCCC,
while there were 12 cases in high expression of Netrin-1 and 60
cases in low expression in normal tissues adjacent to carcinoma.
The difference between the two groups is signiﬁcant
(c2 = 42.921, P＜0.01), indicating that the positive expression
of Netrin-1 protein RCCC is higher than that in normal renal
tissues adjacent to carcinoma; the difference of the positive
expression of Netrin-1 in 72 cases of RCCC in pathological
grade and clinical stage is statistically signiﬁcant (P < 0.05),
showing that the expression of Netrin-1 in RCCC increases with
the increasing pathological grade and clinical stage, which is
agreed by Li et al [16]. It is speculated to be related with the
participation of Netrin-1 in the expression regulation mecha-
nism in tumor [17]: UNC5B is a downstream gene of p53 gene,
containing a p53 binding sequence in its ﬁrst intron. UNC5B
can be regulated down through RNA interference to inhibit
the apoptosis induced by p53 signiﬁcantly, indicating that
UNC5B is an important target of the transcription level of
p53 induced cell apoptosis, and can play a role of promoting
apoptosis. In the case of p53 mutation or deletion in tumor,
the expression of UNC5B decreases signiﬁcantly, and Netrin-
1 can inhibit the apoptosis induced by p53 completely. When
UNC5B combines with Netrin-1, although p53 protein can still
stably be expressed and gather, it is in the inactivated state on
the function. Therefore, Netrin-1 can be considered a proto-
oncogene. It has been found that NF-kB is in the activated
state in the production of tumor, making the expression of a
variety of genes increasing [18]. There is a conserved binding
sequence of NF-kB within the startup regulating zone of
Netrin-1 through DNA horizontal comparison. It can be
proved by the detection of ChIP and genes that NF-kB can
upregulate the expression of Netrin-1, thus inducing cell
migration and survival [19].
4.3. Analysis of the correlation between the
postoperative survival rates of patients with RCCC and
the expression of Netrin-1 protein
It is shown in the study that the 5-year survival rate after
operation in low Netrin-1 protein expression group and in high
Netrin-1 protein expression group was 79％ (17/21) and 62%
(32/51), with no signiﬁcant difference in survival rate between
two group (c2 = 1.360, P = 0.245). Although there is no sig-
niﬁcant difference between groups, we can ﬁnd that the survival
rate in high expression group is lower than that in low expres-
sion group, with an obvious trend. It is inferred to be related to
the limited samples in this study. The next step can be improvingthe study sample size to explore the relationship between the
expression of Netrin-1 and the survival rates of patients more
accurately [20].
In conclusion, the study results show that the expression of
Netrin-1 is signiﬁcantly correlated to the pathological grade and
clinical stage of RCCC, and may be related with the survival rate
of patients. Netrin-1 may become a new biomarker in the
prognosis and diagnosis of RCCC. Through further study on the
speciﬁc mechanism of Netrin-1 in the occurrence and develop-
ment of RCCC, Netrin-1 is expected to improve a new strategy
for the diagnosis and treatment of renal carcinoma.
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